Literature DB >> 31156993

Application of quality improvement techniques to reduce parenteral nutrition wastage in a national intestinal failure unit.

Philip J Allan1,2, Michael Taylor1, Lindsay Harper1, Amrutha Ramu1,2, Claire Guest1, Charlotte Harris3, Simon Lal1.   

Abstract

OBJECTIVES: Parenteral nutrition (PN) costs approximately £80 per day per bag. Unpredictable changes in patients' clinical condition, venous access loss or reasons related to the processes involved in administering PN can lead to PN wastage. Cost efficiencies are imperative to optimise limited resource utilisation in all current healthcare economies. We undertook a quality improvement (QI) project to reduce PN wastage in an adult acute hospital setting. The project SMART's (specific, measurable, achievable, realistic, time-based) objective was reducing in-patient PN wastage by 10% in 9 months using QI methodology on a national intestinal failure unit (IFU).
METHOD: Wastage reasons were evaluated through pareto charts to target waste reduction using 'Plan, Do, Study, Act' (PDSA) cycles. Variation was mapped using c-charts.
RESULTS: 12-week baseline wastage data predicted 1000 bags wasted per annum (p.a.). PDSA cycles actioned included: regular enhanced clinical team awareness of wastage; unused PN bags redistributed within expiry date; stock bag rotation; critical path analysis of PN bag journey; enhanced discharge planning/coordination; reorganisation of fridge PN storage according to weekday; changing ordering frequency and bag type (from tailored to standard) to increase flexibility around discharge date and PN weaning. Implementation of PDSA cycles led to a 34% reduction in PN wastage in 9 months.
CONCLUSION: In a high-use IFU, PN wastage is common and costly. Using a QI approach with concurrent PDSA cycles and a motivated multidisciplinary team, high levels of wastage reduction are possible with associated significant cost savings and from this study a predicted cost saving of approximately £30 000 p.a.

Entities:  

Keywords:  Intestinal Failure; Multidisciplinary; Parenteral Nutrition; Plan Do Study Act cycles; Quality Improvement; Wastage

Year:  2017        PMID: 31156993      PMCID: PMC6452361          DOI: 10.1136/ejhpharm-2016-001197

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  7 in total

Review 1.  Review article: intestinal failure.

Authors:  S Lal; A Teubner; J L Shaffer
Journal:  Aliment Pharmacol Ther       Date:  2006-07-01       Impact factor: 8.171

2.  Controlling variation in health care: a consultation from Walter Shewhart.

Authors:  D M Berwick
Journal:  Med Care       Date:  1991-12       Impact factor: 2.983

3.  Plotting basic control charts: tutorial notes for healthcare practitioners.

Authors:  M A Mohammed; P Worthington; W H Woodall
Journal:  Qual Saf Health Care       Date:  2008-04

4.  A primer on leading the improvement of systems.

Authors:  D M Berwick
Journal:  BMJ       Date:  1996-03-09

5.  Parenteral nutrition at home in management of intestinal failure.

Authors:  P J Milewski; E Gross; I Holbrook; C Clarke; L A Turnberg; M H Irving
Journal:  Br Med J       Date:  1980-06-07

6.  Improving quality in a national intestinal failure unit: greater efficiency, improved access and reduced mortality.

Authors:  Emma Donaldson; Michael Taylor; Arun Abraham; Gordon Carlson; Olivia Fletcher; Jacqui Varden; Antje Teubner; Simon Lal
Journal:  Frontline Gastroenterol       Date:  2014-08-25

7.  ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults.

Authors:  Loris Pironi; Jann Arends; Janet Baxter; Federico Bozzetti; Rosa Burgos Peláez; Cristina Cuerda; Alastair Forbes; Simon Gabe; Lyn Gillanders; Mette Holst; Palle Bekker Jeppesen; Francisca Joly; Darlene Kelly; Stanislaw Klek; Øivind Irtun; S W Olde Damink; Marina Panisic; Henrik Højgaard Rasmussen; Michael Staun; Kinga Szczepanek; André Van Gossum; Geert Wanten; Stéphane Michel Schneider; Jon Shaffer
Journal:  Clin Nutr       Date:  2014-09-21       Impact factor: 7.324

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.